373 related articles for article (PubMed ID: 31046725)
1. Influenza epidemiology and influenza vaccine effectiveness during the 2016-2017 season in the Global Influenza Hospital Surveillance Network (GIHSN).
Baselga-Moreno V; Trushakova S; McNeil S; Sominina A; Nunes MC; Draganescu A; Unal S; Koul P; Kyncl J; Zhang T; Kuatbayeva A; Ben-Salah A; Burtseva E; Puig-Barberà J; Díez-Domingo J;
BMC Public Health; 2019 May; 19(1):487. PubMed ID: 31046725
[TBL] [Abstract][Full Text] [Related]
2. Influenza epidemiology and influenza vaccine effectiveness during the 2015-2016 season: results from the Global Influenza Hospital Surveillance Network.
Puig-Barberà J; Mira-Iglesias A; Burtseva E; Cowling BJ; Serhat U; Ruiz-Palacios GM; Launay O; Kyncl J; Koul P; Siqueira MM; Sominina A;
BMC Infect Dis; 2019 May; 19(1):415. PubMed ID: 31088481
[TBL] [Abstract][Full Text] [Related]
3. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.
Puig-Barberà J; Guglieri-López B; Tortajada-Girbés M; López-Labrador FX; Carballido-Fernández M; Mollar-Maseres J; Schwarz-Chavarri G; Baselga-Moreno V; Mira-Iglesias A; Díez-Domingo J;
Vaccine; 2017 Dec; 35(52):7331-7338. PubMed ID: 29128380
[TBL] [Abstract][Full Text] [Related]
4. 2012-2013 Seasonal influenza vaccine effectiveness against influenza hospitalizations: results from the global influenza hospital surveillance network.
Puig-Barberà J; Natividad-Sancho A; Launay O; Burtseva E; Ciblak MA; Tormos A; Buigues-Vila A; Martínez-Úbeda S; Sominina A;
PLoS One; 2014; 9(6):e100497. PubMed ID: 24945510
[TBL] [Abstract][Full Text] [Related]
5. Influenza vaccine effectiveness against laboratory-confirmed influenza in hospitalised adults aged 60 years or older, Valencia Region, Spain, 2017/18 influenza season.
Mira-Iglesias A; López-Labrador FX; Baselga-Moreno V; Tortajada-Girbés M; Mollar-Maseres J; Carballido-Fernández M; Schwarz-Chavarri G; Puig-Barberà J; Díez-Domingo J;
Euro Surveill; 2019 Aug; 24(31):. PubMed ID: 31387672
[TBL] [Abstract][Full Text] [Related]
6. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals.
Rondy M; Launay O; Puig-Barberà J; Gefenaite G; Castilla J; de Gaetano Donati K; Galtier F; Hak E; Guevara M; Costanzo S; ; Moren A
Euro Surveill; 2015 Jan; 20(2):. PubMed ID: 25613779
[TBL] [Abstract][Full Text] [Related]
7. Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza.
Rondy M; Launay O; Castilla J; Costanzo S; Puig-Barberà J; Gefenaite G; Larrauri A; Rizzo C; Pitigoi D; Syrjänen RK; Machado A; Kurečić Filipović S; Krisztina Horváth J; Paradowska-Stankiewicz I; Marbus S; ; Moren A
Vaccine; 2017 Aug; 35(34):4298-4306. PubMed ID: 28709555
[TBL] [Abstract][Full Text] [Related]
8. Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2014: the Influenza Complications Alert Network (FluCAN).
Blyth CC; Macartney KK; Hewagama S; Senenayake S; Friedman ND; Simpson G; Upham J; Kotsimbos T; Kelly P; Cheng AC
Euro Surveill; 2016 Jul; 21(30):. PubMed ID: 27494798
[TBL] [Abstract][Full Text] [Related]
9. Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019.
Mouratidou E; Lambrou A; Andreopoulou A; Gioula G; Exindari M; Kossyvakis A; Pogka V; Mentis A; Georgakopoulou T; Lytras T
Vaccine; 2020 Mar; 38(12):2715-2724. PubMed ID: 32033848
[TBL] [Abstract][Full Text] [Related]
10. Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012-2015.
Thompson MG; Pierse N; Sue Huang Q; Prasad N; Duque J; Claire Newbern E; Baker MG; Turner N; McArthur C;
Vaccine; 2018 Sep; 36(39):5916-5925. PubMed ID: 30077480
[TBL] [Abstract][Full Text] [Related]
11. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study.
Kissling E; Valenciano M; Larrauri A; Oroszi B; Cohen JM; Nunes B; Pitigoi D; Rizzo C; Rebolledo J; Paradowska-Stankiewicz I; Jiménez-Jorge S; Horváth JK; Daviaud I; Guiomar R; Necula G; Bella A; O'Donnell J; Głuchowska M; Ciancio BC; Nicoll A; Moren A
Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399425
[TBL] [Abstract][Full Text] [Related]
12. Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013-14: Results from the InNHOVE network.
Rondy M; Castilla J; Launay O; Costanzo S; Ezpeleta C; Galtier F; de Gaetano Donati K; Moren A
Hum Vaccin Immunother; 2016 May; 12(5):1217-24. PubMed ID: 27065000
[TBL] [Abstract][Full Text] [Related]
13. 2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project.
Rondy M; Larrauri A; Casado I; Alfonsi V; Pitigoi D; Launay O; Syrjänen RK; Gefenaite G; Machado A; Vučina VV; Horváth JK; Paradowska-Stankiewicz I; Marbus SD; Gherasim A; Díaz-González JA; Rizzo C; Ivanciuc AE; Galtier F; Ikonen N; Mickiene A; Gomez V; Kurečić Filipović S; Ferenczi A; Korcinska MR; van Gageldonk-Lafeber R; ; Valenciano M
Euro Surveill; 2017 Jul; 22(30):. PubMed ID: 28797322
[TBL] [Abstract][Full Text] [Related]
14. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
Kissling E; Valenciano M; Buchholz U; Larrauri A; Cohen JM; Nunes B; Rogalska J; Pitigoi D; Paradowska-Stankiewicz I; Reuss A; Jiménez-Jorge S; Daviaud I; Guiomar R; O'Donnell J; Necula G; Głuchowska M; Moren A
Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556348
[TBL] [Abstract][Full Text] [Related]
15. Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15.
Gherasim A; Pozo F; de Mateo S; Gamarra IA; García-Cenoz M; Vega T; Martínez E; Giménez J; Castrillejo D; Larrauri A;
Vaccine; 2016 Apr; 34(20):2371-7. PubMed ID: 27020713
[TBL] [Abstract][Full Text] [Related]
16. Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccine.
Rose AMC; Kissling E; Gherasim A; Casado I; Bella A; Launay O; Lazăr M; Marbus S; Kuliese M; Syrjänen R; Machado A; Kurečić Filipović S; Larrauri A; Castilla J; Alfonsi V; Galtier F; Ivanciuc A; Meijer A; Mickiene A; Ikonen N; Gómez V; Lovrić Makarić Z; Moren A; Valenciano M;
Influenza Other Respir Viruses; 2020 May; 14(3):302-310. PubMed ID: 32022450
[TBL] [Abstract][Full Text] [Related]
17. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons.
Castilla J; Navascués A; Fernández-Alonso M; Reina G; Pozo F; Casado I; Guevara M; Martínez-Baz I; Barricarte A; Ezpeleta C; ;
Vaccine; 2016 Mar; 34(11):1350-7. PubMed ID: 26854911
[TBL] [Abstract][Full Text] [Related]
19. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
[TBL] [Abstract][Full Text] [Related]
20. Moderate influenza vaccine effectiveness against A(H1N1)pdm09 virus, and low effectiveness against A(H3N2) subtype, 2018/19 season in Italy.
Bellino S; Bella A; Puzelli S; Di Martino A; Facchini M; Punzo O; Pezzotti P; Castrucci MR; The InfluNet Study Group
Expert Rev Vaccines; 2019 Nov; 18(11):1201-1209. PubMed ID: 31674847
[No Abstract] [Full Text] [Related]
[Next] [New Search]
